Recommended Treatment Regimen
Continue bupropion as the foundation and add lamotrigine for mood stabilization, targeting both the cyclic depression and probable bipolar II disorder, while addressing insomnia with cognitive behavioral therapy for insomnia (CBT-I) and transitioning away from chronic zolpidem use.
Rationale for This Approach
Your partial response to bupropion is clinically significant and should be preserved. The cyclic pattern, 30-year duration, and failure of multiple mood stabilizers (lithium, valproate) and antipsychotics (lurasidone, quetiapine, olanzapine) point toward a treatment-resistant bipolar spectrum disorder where lamotrigine offers distinct advantages.
Primary Mood Management
Bupropion + Lamotrigine Combination:
Keep bupropion at its current effective dose. Bupropion has demonstrated benefit in your case and carries lower sexual dysfunction risk than SSRIs 1. For bipolar depression, antidepressants should always be combined with a mood stabilizer 2, 3.
Add lamotrigine as your mood stabilizer. Start at 25 mg daily for 2 weeks, then 50 mg daily for 2 weeks, then 100 mg daily for 1 week, then target 200 mg daily. This slow titration minimizes rash risk. Lamotrigine is FDA-approved for bipolar maintenance 3 and shows particular efficacy for bipolar depression and preventing depressive recurrences 4, 5. Given your failure of lithium and valproate, lamotrigine represents the next evidence-based option 2.
Why not retry antipsychotics? You've failed quetiapine, olanzapine, and lurasidone—three of the strongest evidence-based options for bipolar depression 6, 7, 8. While lurasidone and cariprazine are newer FDA-approved options 4, 9, your prior failures with this drug class and the metabolic/sedation concerns make lamotrigine the more rational choice.
Addressing the Gambling Disorder
The cyclic gambling behavior (6-12 month cycles with slot machines specifically) suggests impulse control dysregulation tied to your mood cycling. Naltrexone 50 mg daily should be added once mood is stabilized on lamotrigine (after 8-12 weeks). Naltrexone targets opioid pathways involved in reward-seeking behavior and has evidence for gambling disorder. The combination naltrexone-bupropion exists commercially 10, but given your established bupropion response, adding standalone naltrexone allows dose optimization of each agent independently.
Insomnia Management
Critical concern: Chronic zolpidem use with poor sleep quality ("like a war") indicates tolerance and rebound insomnia—a common pitfall with long-term benzodiazepine receptor agonists.
Immediate steps:
Initiate CBT-I (cognitive behavioral therapy for insomnia) as first-line treatment 11. This includes stimulus control therapy, sleep restriction therapy, and relaxation techniques. CBT-I is more effective long-term than medications and is specifically recommended as initial intervention 12, 11.
Transition from zolpidem: Once CBT-I begins (within 2-4 weeks), gradually taper zolpidem by 5 mg every 5-7 days while implementing behavioral strategies. The guideline explicitly states zolpidem and similar agents should be short-term only 12.
If pharmacotherapy still needed after CBT-I trial: Consider low-dose trazodone (25-100 mg at bedtime) or mirtazapine (7.5-15 mg at bedtime). Mirtazapine has dual benefits—it addresses insomnia and has antidepressant properties with faster onset than SSRIs 1. However, weight gain is a concern. Trazodone is sedating with lower metabolic risk but can cause morning grogginess.
Avoid: Quetiapine for insomnia (you've already failed it, and using antipsychotics solely for sleep carries metabolic risks without mood benefit in your case). Antihistamines are not recommended for chronic insomnia 12.
Borderline Personality Features
The borderline traits complicate treatment but don't fundamentally change the pharmacologic approach. Dialectical behavior therapy (DBT) should be pursued concurrently with medication management. Mood stabilization with lamotrigine may reduce affective instability that overlaps with borderline symptoms.
Monitoring and Follow-Up
- Week 2-4: Assess bupropion tolerability, lamotrigine titration adherence, and begin CBT-I
- Week 6-8: Evaluate mood response, continue lamotrigine titration, assess sleep improvement with behavioral interventions
- Week 12: Reassess mood stability. If inadequate response (less than 50% improvement in depressive symptoms), consider adding low-dose quetiapine (50-300 mg) specifically for bipolar depression 5, 7 despite prior trial—sometimes combinations work when monotherapy fails
- Week 12-16: If mood stable, add naltrexone for gambling behavior
- Ongoing: Monitor for lamotrigine rash (highest risk in first 8 weeks), assess suicidality given antidepressant use 1, and track mood cycling patterns
Common Pitfalls to Avoid
- Don't abandon bupropion prematurely—partial response is worth building upon
- Don't rush lamotrigine titration—rash risk is real and dose-dependent
- Don't continue chronic zolpidem—you're experiencing tolerance and rebound insomnia
- Don't add antidepressants without mood stabilizer coverage—risk of mood destabilization 2, 3
- Don't expect immediate results—lamotrigine takes 6-8 weeks at therapeutic dose for full effect 4
If This Regimen Fails
After 12 weeks at therapeutic lamotrigine doses (200 mg) with continued bupropion:
- Next step: Add quetiapine 50-300 mg for bipolar depression 5, 7, 8 or consider lurasidone rechallenge at different dosing
- Alternative: Trial of lithium rechallenge with closer monitoring, as lithium has unique anti-suicide properties 5, 13 and remains gold standard despite your prior failure
- Last resort: Olanzapine-fluoxetine combination is FDA-approved for bipolar depression 3, 6 and ranked highest for effect size 8, but metabolic concerns are substantial
Duration of Treatment
Given 30-year history with multiple episodes, maintenance treatment should continue at least 2 years after achieving stability 2, and likely indefinitely given chronicity and treatment resistance. Lithium or lamotrigine are recommended for long-term bipolar maintenance 2, 5.